← Open Payments lookup

NOSAYABA OSAZUWA: Open Payments

NPI 1932771391 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 59 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $167 · 2025 $1,519

Food & beverage: $1,519
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$426
Otsuka America Pharmaceutical, Inc.8$187
Janssen Pharmaceuticals, Inc7$182
Neurocrine BioSciences, Inc.2$163
E.R. Squibb & Sons, L.L.C.8$140
Alkermes, Inc.4$87
Axsome Therapeutics, Inc.3$80
Collegium Pharmaceutical, Inc.3$63
ABBVIE INC.3$60
Vanda Pharmaceuticals Inc.1$28

Products named: CAPLYTA, REXULTI, INGREZZA, COBENFY, INVEGA SUSTENNA, ARISTADA, Auvelity, SPRAVATO.

Industry payments across CA — which companies pay providers there.